DEXWireNews

Unusual Accumulation in EVOKE PHARMA INC. Keep watch

NASDAQ:EVOK   Evoke Pharma, Inc.
Keep on your watchlist for continuation in price action and buy side volume, looks like accumulation is underway and the fact it is a Pharmaceutical stock, Trial data or FDA releases could be the stimulus.
Very speculative, but very rewarding trade setup on the chart.

COMPANY PROFILE
Evoke Pharma, Inc. is a pharmaceutical company, which engages in the development of drugs for the treatment of gastrointestinal disorders and diseases. It develops Gimoti, with promotility and anti-emetic effects, for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women with diabetes mellitus. The company was founded by Matthew J. D'Onofrio, Cam L. Garner, Scott L. Glenn, and David A. Gonyer in January 2007 and is headquartered in Solana Beach, CA.

⭐⭐⭐ Sign Up for Free ⭐⭐⭐

1) Download our App on Google Play! dexwirenews.com/APP

2) Text Message Notifications: dexwirenews.com/SMS

3) Telegram: t.me/DEXWireNews

4) Follow Us on our Social Networks
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.